Market Overview

Benzinga's Biggest Movers For The Week Of May 14, 2018


The data presented below was compiled using a Screener widget and a Newsfeed widget on the Benzinga Pro platform. The Screener is customizable and is available for the pre-market and after-hours sessions in addition the the intraday session. To try out these widgets, sign up for a trial of the Benzinga Pro platform.

Percentage changes in prices below refer to total weekly change.

Biggest Gainers

  • Seadrill Ltd (NYSE: SDRL) - Gained 89.7 percent on high trading volume despite no company-specific or fundamental news.
  • ADOMANI Inc (NASDAQ: ADOM) - Gained 83.4 percent on Friday alone; No formal news regarding the company.
  • VIVUS Inc (NASDAQ: VVUS) - Shares up 48.8 percent for the week after the company received letter from Nasdaq regarding continued listing subject to certain conditions; The company must have effected reverse stock split, evidenced closing bid by October 1.
  • VAALCO Energy Inc (NYSE: EGY) - Up 40.7 percent in sympathy with other energy and petroleum stocks after Thursday news of oil rebound.
  • Black Box Corp (NASDAQ: BBOX) - Up 39.2 percent despite no company-specific news.

Biggest Losers

  • Agile Therapeutics Inc (NASDAQ: AGRX) - Down 75 percent after the FDA on Friday announced significant concerns regarding the company’s Twirla contraceptive.
  • Cesca Therapeutics Inc (NASDAQ: KOOL) - Down 52.8 percent. The company on Monday reported Q1 EPS and Sales down YoY, and on Wednesday priced a ~9.2 million share offering at 60 cents per share. With ~11.5 million shares outstanding, it could also be attracting low-float interest.
  • Netshoes (Cayman) Ltd (NYSE: NETS) - Down 48.8 percent. The company reported a Q1 earnings miss on Monday and was downgraded by JPMorgan on Wednesday.
  • ATyr Pharma Inc (NASDAQ: LIFE) - Down 39.8 percent. The company on Monday reported a Q1 miss and announced it would undergo a restructuring, including a 30-percent workforce reduction.
  • Jounce Therapeutics Inc (NASDAQ: JNCE) - Down 34.9 percent after a ASCO abstract released Wednesday. Abstract showed the company’s JTX-2011 0.3mg/kg had 'no substantial change in number of peripheral Teff or Tregs'.

Related Articles (AGRX + ADOM)

View Comments and Join the Discussion!

Posted-In: News After-Hours Center Movers Trading Ideas